Skip to main content

Table 1 Comparison of DSS1 gene expression among various groups of breast cancer patients

From: Breast cancers with high DSS1 expression that potentially maintains BRCA2 stability have poor prognosis in the relapse-free survival

Clinical parameters Group Number of patient DSS1gene expression median (25%, 75%) Mann–Whitney U-test (P)
Menopause Pre- 78 48.7 (8.05, 143) 0.554
  Post- 210 49.2 (8.09, 92.4)  
Nodal (-) 179 41.2 (7.04, 94.2) 0.132
status (+) 110 64.9 (13.2, 117)  
Tumor < 20 125 44.3 (8.08, 108) 0.646
size (mm) ≥ 20 164 52.2 (8.41, 104)  
Nuclear 1 143 51.7 (8.33, 114) 0.703
grade 2 74 39.7 (8.24, 90.0)  
  3 72 57.5 (6.19, 91.3)  
Vessel (-) 187 40.0 (5.47, 88.9) 0.308
invasion (+) 77 47.1 (11.5, 107)  
ERα (-) 65 52.7 (5.71, 105) 0.962
  (+) 224 49.0 (8.36, 102)  
PgR (-) 96 60.3 (6.14, 103) 0.487
  (+) 193 47.1 (8.37, 106)  
HER2 (-) 248 53.2 (10.6, 115) *0.0255
  (+) 41 21.8 (3.78, 74.8)  
Ki67 < 20 113 55.6 (16.4, 132) **0.0096
(%) ≥ 20 169 36.0 (4.97, 82.0)  
  1. (*) and (**) denote P < 0.05 and P < 0.01, respectively.